fluorecare® – SARS-CoV-2 & Infl. A/B & RSV Combined Test for home use
- Article ID
- Handling time
The fluorecare® SARS-CoV-2 & Influenza A/B & RSV Antigen Combined Test Kit is applicable to the simultaneous qualitative detection and differentiation of novel Coronavirus (SARS-CoV-2 Antigen), Influenza A virus, Influenza B virus Antigen and/or RSV Antigen in population Nasal swabs samples in vitro.
It can be used as an aid to diagnose coronavirus infection disease (COVID-19), caused by SARS-CoV-2, in symptomatic patients within 7 days of onset. It can also be used to aid in the diagnosis of diseases caused by Influenza A/B or RSV. For in vitro diagnostic use only. For self-testing use.
The SARS-CoV-2 & Influenza A/B & RSV Antigen test is a qualitatively test to detect SARS-CoV-2 Antigen/Influenza A/B Antigen/RSV Antigen in Nasal swabs samples by the colloidal gold method. After sample added, the SARS-CoV-2 Antigen (or Influenza A/B & RSV) in the sample to be tested is combined with the SARS-CoV-2 (or Influenza A/B & RSV) antibody labelled with colloidal gold on the Conjugate pad to form the SARS-CoV-2 Antigen (or Influenza A/B & RSV) antibody-colloidal gold complex. Due to chromatography, the SARS-CoV-2 Antigen (or Influenza A/B & RSV)-antibody-colloidal gold complex diffuses along the nitrocellulose’s membrane. Within the detection line area, the SARS-CoV-2 Antigen (or Influenza A/B & RSV)-antibody complex binds to the antibody enclosed within the detection line area, showing a purple-red band. Colloidal gold labelled SARS-CoV-2 (or Influenza A/B & RSV) antibody diffuses to the quality control line (C) region and is captured by Goat anti-mouse IgG to form red bands. When the reaction is over, the results can be interpreted by visual observation.